- Based on a per-protocol interim analysis of safety and efficacy data, the Independent Data Monitoring Committee (IDMC) recommended that the trial continue without modifications- No new safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback